HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $23 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on MediWound (NASDAQ:MDWD) and maintained a $23 price target.
August 17, 2023 | 10:22 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MediWound's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $23.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $23 indicates the firm's continued confidence in the stock's potential, which could lead to increased investor interest and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100